Do analysts rate SNWV or CNXU?

Sanuwave Health currently has a consensus target price of $51.00, indicating a potential upside of 242.05%. Given Sanuwave Health's stronger consensus rating and higher possible upside, equities analysts clearly believe Sanuwave Health is more favorable than Conexeu Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanuwave Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50 Conexeu Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings and valuation, SNWV or CNXU?

Sanuwave Health has higher revenue and earnings than Conexeu Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sanuwave Health $44.05M 2.91 $11.81M $0.33 45.18 Conexeu Sciences N/A N/A N/A N/A N/A

Sanuwave Health (SNWV) Competitors

$14.91 0.00 (0.00%)

Closing price 06/12/2026 04:00 PM Eastern

Extended Trading

$14.97 +0.06 (+0.40%)

As of 06/12/2026 04:04 PM Eastern

Compare

SNWV vs. KIDS, CLPT, CNXU, DCTH, and CV

Should you buy Sanuwave Health stock or one of its competitors? MarketBeat compares Sanuwave Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sanuwave Health include OrthoPediatrics (KIDS), ClearPoint Neuro (CLPT), Conexeu Sciences (CNXU), Delcath Systems (DCTH), and CapsoVision (CV). These companies are all part of the "medical equipment" industry.

How does Sanuwave Health compare to OrthoPediatrics?

OrthoPediatrics (NASDAQ:KIDS) and Sanuwave Health (NASDAQ:SNWV) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

OrthoPediatrics presently has a consensus target price of $24.44, suggesting a potential upside of 37.17%. Sanuwave Health has a consensus target price of $51.00, suggesting a potential upside of 242.05%. Given Sanuwave Health's higher probable upside, analysts plainly believe Sanuwave Health is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, OrthoPediatrics had 2 more articles in the media than Sanuwave Health. MarketBeat recorded 3 mentions for OrthoPediatrics and 1 mentions for Sanuwave Health. Sanuwave Health's average media sentiment score of 1.89 beat OrthoPediatrics' score of 0.63 indicating that Sanuwave Health is being referred to more favorably in the news media.

Company	Overall Sentiment
OrthoPediatrics	Positive
Sanuwave Health	Very Positive

Sanuwave Health has a net margin of 35.96% compared to OrthoPediatrics' net margin of -16.31%. OrthoPediatrics' return on equity of -7.01% beat Sanuwave Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-16.31%	-7.01%	-4.86%
Sanuwave Health	35.96%	-450.56%	44.87%

69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are owned by institutional investors. 31.8% of OrthoPediatrics shares are owned by company insiders. Comparatively, 14.4% of Sanuwave Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

OrthoPediatrics has a beta of 1.03, meaning that its stock price is 3% more volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.34, meaning that its stock price is 34% more volatile than the broader market.

Sanuwave Health has lower revenue, but higher earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	1.94	-$39.65M	-$1.68	N/A
Sanuwave Health	$44.05M	2.91	$11.81M	$0.33	45.18

Summary

Sanuwave Health beats OrthoPediatrics on 9 of the 16 factors compared between the two stocks.

How does Sanuwave Health compare to ClearPoint Neuro?

Sanuwave Health (NASDAQ:SNWV) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

Sanuwave Health has higher revenue and earnings than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	2.91	$11.81M	$0.33	45.18
ClearPoint Neuro	$36.97M	10.90	-$25.54M	-$1.01	N/A

Sanuwave Health currently has a consensus target price of $51.00, indicating a potential upside of 242.05%. ClearPoint Neuro has a consensus target price of $18.00, indicating a potential upside of 33.93%. Given Sanuwave Health's stronger consensus rating and higher possible upside, equities analysts clearly believe Sanuwave Health is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Sanuwave Health has a beta of 1.34, meaning that its share price is 34% more volatile than the broader market. Comparatively, ClearPoint Neuro has a beta of 1.31, meaning that its share price is 31% more volatile than the broader market.

In the previous week, Sanuwave Health and Sanuwave Health both had 1 articles in the media. Sanuwave Health's average media sentiment score of 1.89 beat ClearPoint Neuro's score of 1.87 indicating that Sanuwave Health is being referred to more favorably in the media.

Company	Overall Sentiment
Sanuwave Health	Very Positive
ClearPoint Neuro	Very Positive

Sanuwave Health has a net margin of 35.96% compared to ClearPoint Neuro's net margin of -71.57%. ClearPoint Neuro's return on equity of -140.96% beat Sanuwave Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	35.96%	-450.56%	44.87%
ClearPoint Neuro	-71.57%	-140.96%	-36.98%

42.5% of Sanuwave Health shares are owned by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are owned by institutional investors. 14.4% of Sanuwave Health shares are owned by insiders. Comparatively, 6.9% of ClearPoint Neuro shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Sanuwave Health beats ClearPoint Neuro on 13 of the 16 factors compared between the two stocks.

How does Sanuwave Health compare to Conexeu Sciences?

Sanuwave Health (NASDAQ:SNWV) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

Sanuwave Health has a net margin of 35.96% compared to Conexeu Sciences' net margin of 0.00%. Conexeu Sciences' return on equity of 0.00% beat Sanuwave Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	35.96%	-450.56%	44.87%
Conexeu Sciences	N/A	N/A	N/A

42.5% of Sanuwave Health shares are owned by institutional investors. 14.4% of Sanuwave Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Sanuwave Health has higher revenue and earnings than Conexeu Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	2.91	$11.81M	$0.33	45.18
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A

Sanuwave Health currently has a consensus target price of $51.00, indicating a potential upside of 242.05%. Given Sanuwave Health's stronger consensus rating and higher possible upside, equities analysts clearly believe Sanuwave Health is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Conexeu Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Conexeu Sciences had 2 more articles in the media than Sanuwave Health. MarketBeat recorded 3 mentions for Conexeu Sciences and 1 mentions for Sanuwave Health. Sanuwave Health's average media sentiment score of 1.89 beat Conexeu Sciences' score of 0.44 indicating that Sanuwave Health is being referred to more favorably in the media.

Company	Overall Sentiment
Sanuwave Health	Very Positive
Conexeu Sciences	Neutral

Summary

Sanuwave Health beats Conexeu Sciences on 10 of the 12 factors compared between the two stocks.

How does Sanuwave Health compare to Delcath Systems?

Sanuwave Health (NASDAQ:SNWV) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk.

Sanuwave Health currently has a consensus target price of $51.00, indicating a potential upside of 242.05%. Delcath Systems has a consensus target price of $22.50, indicating a potential upside of 91.98%. Given Sanuwave Health's stronger consensus rating and higher probable upside, research analysts clearly believe Sanuwave Health is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43

42.5% of Sanuwave Health shares are owned by institutional investors. Comparatively, 61.1% of Delcath Systems shares are owned by institutional investors. 14.4% of Sanuwave Health shares are owned by company insiders. Comparatively, 19.4% of Delcath Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Sanuwave Health has a beta of 1.34, meaning that its stock price is 34% more volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market.

In the previous week, Delcath Systems had 1 more articles in the media than Sanuwave Health. MarketBeat recorded 2 mentions for Delcath Systems and 1 mentions for Sanuwave Health. Sanuwave Health's average media sentiment score of 1.89 beat Delcath Systems' score of 0.94 indicating that Sanuwave Health is being referred to more favorably in the media.

Company	Overall Sentiment
Sanuwave Health	Very Positive
Delcath Systems	Positive

Sanuwave Health has a net margin of 35.96% compared to Delcath Systems' net margin of 0.62%. Delcath Systems' return on equity of 0.51% beat Sanuwave Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	35.96%	-450.56%	44.87%
Delcath Systems	0.62%	0.51%	0.46%

Sanuwave Health has higher earnings, but lower revenue than Delcath Systems. Sanuwave Health is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	2.91	$11.81M	$0.33	45.18
Delcath Systems	$85.23M	4.75	$2.70M	$0.01	1,172.00

Summary

Sanuwave Health beats Delcath Systems on 9 of the 17 factors compared between the two stocks.

How does Sanuwave Health compare to CapsoVision?

CapsoVision (NASDAQ:CV) and Sanuwave Health (NASDAQ:SNWV) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, media sentiment, earnings, risk and analyst recommendations.

In the previous week, CapsoVision had 1 more articles in the media than Sanuwave Health. MarketBeat recorded 2 mentions for CapsoVision and 1 mentions for Sanuwave Health. Sanuwave Health's average media sentiment score of 1.89 beat CapsoVision's score of 1.32 indicating that Sanuwave Health is being referred to more favorably in the news media.

Company	Overall Sentiment
CapsoVision	Positive
Sanuwave Health	Very Positive

CapsoVision presently has a consensus target price of $8.50, indicating a potential upside of 18.22%. Sanuwave Health has a consensus target price of $51.00, indicating a potential upside of 242.05%. Given Sanuwave Health's higher possible upside, analysts plainly believe Sanuwave Health is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Sanuwave Health has a net margin of 35.96% compared to CapsoVision's net margin of -198.87%. CapsoVision's return on equity of 0.00% beat Sanuwave Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CapsoVision	-198.87%	N/A	-136.03%
Sanuwave Health	35.96%	-450.56%	44.87%

42.5% of Sanuwave Health shares are owned by institutional investors. 2.3% of CapsoVision shares are owned by insiders. Comparatively, 14.4% of Sanuwave Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Sanuwave Health has higher revenue and earnings than CapsoVision. CapsoVision is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CapsoVision	$13.55M	26.51	-$25.32M	-$2.34	N/A
Sanuwave Health	$44.05M	2.91	$11.81M	$0.33	45.18

Summary

Sanuwave Health beats CapsoVision on 10 of the 13 factors compared between the two stocks.

Get Sanuwave Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNWV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SNWV vs. The Competition

Export

Metric	Sanuwave Health	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$128.23M	$8.31B	$6.52B	$12.05B
Dividend Yield	N/A	2.50%	2.67%	5.66%
P/E Ratio	45.18	15.64	24.00	24.42
Price / Sales	2.91	7.06	514.36	111.24
Price / Cash	8.78	17.44	27.48	37.92
Price / Book	78.47	3.62	10.54	6.82
Net Income	$11.81M	$224.06M	$3.57B	$337.56M
7 Day Performance	2.47%	-1.40%	0.60%	1.17%
1 Month Performance	-11.51%	4.39%	1.56%	3.16%
1 Year Performance	-49.80%	-0.88%	25.42%	30.58%

Sanuwave Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SNWV Sanuwave Health	2.2348 of 5 stars	$14.91 flat	$51.00 +242.1%	-49.8%	$128.23M	$44.05M	45.18	40	Positive News
KIDS OrthoPediatrics	3.0041 of 5 stars	$18.32 +1.2%	$24.44 +33.4%	-15.8%	$470.55M	$236.35M	N/A	200
CLPT ClearPoint Neuro	2.6274 of 5 stars	$12.89 -10.0%	$18.00 +39.6%	+16.5%	$386.57M	$36.97M	N/A	110	Gap Up
CNXU Conexeu Sciences	N/A	$15.24 -4.8%	N/A	N/A	$385.12M	N/A	N/A	4	Short Interest Increase Gap Up
DCTH Delcath Systems	2.7389 of 5 stars	$10.67 -1.1%	$22.50 +110.9%	-23.6%	$368.35M	$85.23M	1,067.00	60	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SNWV) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sanuwave Health (SNWV) Competitors

SNWV vs. KIDS, CLPT, CNXU, DCTH, and CV

How does Sanuwave Health compare to OrthoPediatrics?

Summary

How does Sanuwave Health compare to ClearPoint Neuro?

Summary

How does Sanuwave Health compare to Conexeu Sciences?

Summary

How does Sanuwave Health compare to Delcath Systems?

Summary

How does Sanuwave Health compare to CapsoVision?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNWV vs. The Competition

Sanuwave Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sanuwave Health (SNWV) Competitors

SNWV vs. KIDS, CLPT, CNXU, DCTH, and CV

How does Sanuwave Health compare to OrthoPediatrics?

Do analysts prefer KIDS or SNWV?

Does the media favor KIDS or SNWV?

Is KIDS or SNWV more profitable?

Do institutionals & insiders have more ownership in KIDS or SNWV?

Which has more volatility & risk, KIDS or SNWV?

Which has stronger earnings & valuation, KIDS or SNWV?

Summary

How does Sanuwave Health compare to ClearPoint Neuro?

Which has preferable valuation and earnings, SNWV or CLPT?

Do analysts recommend SNWV or CLPT?

Which has more volatility and risk, SNWV or CLPT?

Does the media refer more to SNWV or CLPT?

Is SNWV or CLPT more profitable?

Do institutionals & insiders believe in SNWV or CLPT?

Summary

How does Sanuwave Health compare to Conexeu Sciences?

Is SNWV or CNXU more profitable?

Do insiders & institutionals hold more shares of SNWV or CNXU?

Which has stronger earnings and valuation, SNWV or CNXU?

Do analysts rate SNWV or CNXU?

Does the media favor SNWV or CNXU?

Summary

How does Sanuwave Health compare to Delcath Systems?

Do analysts recommend SNWV or DCTH?

Do insiders and institutionals believe in SNWV or DCTH?

Which has more volatility & risk, SNWV or DCTH?

Does the media refer more to SNWV or DCTH?

Is SNWV or DCTH more profitable?

Which has higher earnings and valuation, SNWV or DCTH?

Summary

How does Sanuwave Health compare to CapsoVision?

Does the media prefer CV or SNWV?

Do analysts prefer CV or SNWV?

Is CV or SNWV more profitable?

Do institutionals & insiders believe in CV or SNWV?

Which has preferable valuation and earnings, CV or SNWV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNWV vs. The Competition

Sanuwave Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools